2 unknown, 1 completed, 1 not yet recruiting, 1 recruiting. 6 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 6 | Unknown 2, Completed 1, Not yet recruiting 1, Recruiting 1, Terminated 1 |
Follow Cloxacillin: new trials by email Literature Review of Cloxacillin trials Research Report on Cloxacillin
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Antibiotic Tissue Penetration and Tissue Response in Head and Neck Infection and Reconstructive Surgery Cefuroxime, Dicloxacillin, Cloxacillin - Surgical Wound Infection, Neck Infection | Phase 4 | Not yet recruiting | Tejs Ehlers Klug | 16 | 2026-10-01 | 2026-10-26 |
| Comparison of Cloxacillin and Benzylpenicillin in Penicillin Susceptible S. Aureus Bacteraemia Penicillin G_1200mg, cloxacillin - Staphylococcus Aureus Bacteraemia, Staphylococcal Bacteraemia | Phase 4 | Recruiting | Region Skane | 420 | 2025-03-10 | 2026-04-30 |
| Ceftriaxone as Home IV for Staph Infections Ceftriaxone, Usual Antibiotics (Cloxacillin, Cefazolin, Daptomycin) - Staphylococcal Infections, Osteomyelitis | Phase 4 | Unknown | Vancouver Island Health Authority | 310 | 2019-07-11 | 2019-10-28 |
| Study of Daptomycin Safety and Efficacy for Complicated Skin and Skin Structure Infections (cSSSI) and Bacteremia in Renal Impairment Vancomycin, Daptomycin, Semi-Synthetic Penicillin - Complicated Skin and Skin Structure Infections, S. Aureus Bacteremia | Phase 4 | Terminated | Cubist Pharmaceuticals LLC, a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA) | 92 | 2010-04-19 | 2018-09-05 |
| Safety and Efficacy Study of Daptomycin in Pediatric Participants (1 to 17 Years-old) With Skin and Skin Structure Infections Daptomycin, Standard of Care (SOC) - Skin Diseases, Infectious | Phase 4 | Completed | Cubist Pharmaceuticals LLC, a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA) | 396 | 2008-07-23 | 2018-09-05 |
| Rifampin Combination Therapy Versus Monotherapy in Early Staphylococcal Infections After Total Hip and Knee Arthroplasty Rifampin-combination therapy, Monotherapy - Prosthesis-related Infections, Staphylococcal Infections | Phase 4 | Unknown | Oslo University Hospital | 100 | 2006-04-01 | 2013-06-27 |
Staphylococcal Infections (2) · Abscess (1) · Arthritis, Infectious (1) · Bacteremia (1) · Central Nervous System Infections (1) · Osteomyelitis (1) · Prosthesis-Related Infections (1) · Renal Insufficiency (1) · Skin Diseases, Infectious (1) · Surgical Wound Infection (1)
Cubist Pharmaceuticals LLC, a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA) (2) · Oslo University Hospital (1) · Region Skane (1) · Tejs Ehlers Klug (1) · Vancouver Island Health Authority (1)
United States (2) · Canada (1) · Denmark (1) · India (1) · Norway (1) · Panama (1) · Sweden (1)
Ellie Hershberger (1) · Ellie Hershberger, Pharm.D. (1) · Eric Partlow, MD, FRCPC (1) · Finnur Snorrason, M.D, Ph.D (1) · Malin Hagstrand Aldman, PhD, MD (1) · Tejs Ehlers Klug, MD, DMSc (1)
2023 (1)